Does NADROPARIN Cause Pulmonary embolism? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Pulmonary embolism have been filed in association with NADROPARIN. This represents 4.0% of all adverse event reports for NADROPARIN.
27
Reports of Pulmonary embolism with NADROPARIN
4.0%
of all NADROPARIN reports
5
Deaths
18
Hospitalizations
How Dangerous Is Pulmonary embolism From NADROPARIN?
Of the 27 reports, 5 (18.5%) resulted in death, 18 (66.7%) required hospitalization, and 1 (3.7%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADROPARIN. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does NADROPARIN Cause?
Foetal exposure during pregnancy (81)
Off label use (77)
Premature baby (73)
Maternal exposure during pregnancy (72)
Drug ineffective (54)
Sepsis (46)
Dyspnoea (44)
Fall (43)
Exposure during pregnancy (42)
Confusional state (40)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which NADROPARIN Alternatives Have Lower Pulmonary embolism Risk?
NADROPARIN vs NAFARELIN
NADROPARIN vs NAFCILLIN
NADROPARIN vs NAFCILLIN\NAFCILLIN
NADROPARIN vs NAFRONYL
NADROPARIN vs NAFTIFINE